TRANSPHARMATION LTD.

Company number 07348226 · Active · London NW1 0NH

C
Firmoscan score 62/100

TRANSPHARMATION LTD. is an active private limited company (company number 07348226) incorporated on 17 August 2010, registered in London. Its registered activity is other professional, scientific and technical activities n.e.c. (SIC 74909). Latest small accounts cover the period ending 31 December 2024, showing net assets of £4.48m and cash of £616k, with 28 employees on average. Net assets fell 32% on the prior period (£6.58m).

By net assets it sits in the top quarter of 7,601 comparable companies in London (median £3,258, upper quartile £44k).

Key dates

Incorporated
17 August 2010
Next accounts due
30 September 2026 — 19 days overdue
Confirmation statement due
31 August 2027 — in 316 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 74909
Other professional, scientific and technical activities n.e.c.
Accounts type
Total Exemption Full
Size band
Small (Companies Act thresholds)

Financials — 2 periods on record, latest ending 31 December 2024

Net assets
Net assetsDec 2023: £6.58m; Dec 2024: £4.48m£6.58m£4.48mDec 2023Dec 2024
Cash at bank
Cash at bankDec 2023: £4.35m; Dec 2024: £616k£4.35m£616kDec 2023Dec 2024
Average employees
Average employeesDec 2023: 24; Dec 2024: 282428Dec 2023Dec 2024
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2024£4.48m£616k£4.96m£1.10m——28
31 December 2023£6.58m£4.35m£3.36m£1.15m——24
Current ratio
5.06 — comfortable
Cash per employee
£22k

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

Firmoscan score: 62/100 (grade C)

A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.

Ownership and control

  • (persons with significant control statement) — · since 30 July 2024
  • Mr Mark Steven Duxon — owns 25–50% of shares · since 1 July 2016 · ceased 3 December 2021
  • Vivocore Inc. (corporate entity, Canada) — owns 75–100% of shares · since 17 August 2021 · ceased 1 December 2021
  • Mr Joseph Araujo — owns 25–50% of shares; holds 25–50% of voting rights · since 1 December 2021 · ceased 30 July 2024

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.

Similar companies in London

Same activity (other professional, scientific and technical activities n.e.c.), closest in incorporation date.

Reminders for TRANSPHARMATION LTD.

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.